Is Wanbury Ltd a good quality company?

MoneyWorks4Me analysed the past 10-year performance of Wanbury Ltd and arrived at the following conclusion.

Is the current market price of Wanbury Ltd a good price to buy it?

The 5-year analysis of Wanbury Ltd's performance infers.

What is Wanbury Ltd share price return in the past 10 years?

We analysed the performance of Wanbury Ltd share prices over the last 10 years. Here is what we found out:

What is a Financial Track Record? How to read this chart in order to understand the data present here?

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance

Difference between Standalone Basis and Consolidated basis? Which method is preferred for Wanbury Ltd

Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.

What is CAGR? What does CAGR table indicate for Wanbury Ltd?

Compounded average growth rate (CAGR) measures the average annual growth rate compounded year-on-year over a period of time.

Wanbury gets nod to settle debt by selling few brands

Wanbury Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524212 | NSE: WANBURY

03 Jun 2019

Evaluate

Wanbury has received approval for debt settlement and fund raising plan by sale of few brands. The Board of Directors of the Company at its meeting held on June 01, 2019 has approved the same.

Wanbury is the fastest growing pharma company and has a strong presence in the domestic branded formulations.

Related Wanbury Ltd. Links:

Analysis

Reports

News

Stock Price

Sector News